14-day Premium Trial Subscription Sign Up For FreeGet Free

When Should You SELL Your Stocks? Click to watch.

Adaptimmune Therapeutics plc Stock Forecast

NASDAQ:ADAP BUY SELL

$1.67 (13.61%)

Volume: 785.467k

Closed: May 19, 2022

Hollow Logo Score: -1.728

Adaptimmune Therapeutics plc Stock Forecast

BUY SELL NASDAQ:ADAP
$1.67 (13.61%)

Volume: 785.467k

Closed: May 19, 2022

Score Hollow Logo -1.728

Adaptimmune Therapeutics plc Stock Forecast NASDAQ:ADAP

Price Target and Analyst Ratings

Historical Ratings

Date Upside / Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
2022-05-09 79.64% SVB Leerink $2.00 $3.00 Maintains Market Perform
2022-03-15 79.64% SVB Leerink $7.00 $3.00 Maintains Market Perform
2021-09-22 319.16% Wells Fargo $6.00 $7.00 Maintains Equal-Weight
2021-09-13 319.16% SVB Leerink $6.00 $7.00 Maintains Market Perform
2021-09-07 259.28% SVB Leerink $5.00 $6.00 Maintains Market Perform
2021-08-10 199.4% SVB Leerink $6.00 $5.00 Maintains Market Perform
2021-05-28 139.52% Barclays $4.00 Initiates Coverage On Underweight
2020-11-05 259.28% SVB Leerink $10.00 $6.00 Maintains Market Perform
2020-08-06 498.8% SVB Leerink $11.00 $10.00 Maintains Market Perform
2020-06-01 438.92% Mizuho $3.00 $9.00 Maintains Neutral
2020-04-27 199.4% Citigroup $8.00 $5.00 Maintains Buy
2020-04-22 79.64% Mizuho $3.00 Initiates Coverage On Neutral
2019-08-02 - Guggenheim - Downgrades Buy Neutral
2019-05-31 319.16% Roth Capital $7.00 Initiates Coverage On Buy
2019-05-30 379.04% Citigroup $8.00 Assumes Buy

ADAP Stock Trend

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -31.69% during the next 3 months and, with a 90% probability hold a price between $0.74 and $1.27 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2022-05-23 $1.07 $1.45 $1.84
2022-05-24 $1.05 $1.44 $1.83
2022-05-25 $1.04 $1.43 $1.81
2022-05-26 $1.02 $1.41 $1.80
2022-05-27 $1.01 $1.40 $1.79
2022-05-31 $1.00 $1.38 $1.77
2022-06-01 $0.98 $1.37 $1.76
2022-06-02 $0.97 $1.36 $1.74
2022-06-03 $0.95 $1.34 $1.73
2022-06-06 $0.94 $1.33 $1.72
2022-06-07 $0.93 $1.31 $1.70
2022-06-08 $0.91 $1.30 $1.69
2022-06-09 $0.90 $1.28 $1.67
2022-06-10 $0.88 $1.27 $1.66
2022-06-13 $0.87 $1.26 $1.64
2022-06-14 $0.85 $1.24 $1.63
2022-06-15 $0.84 $1.23 $1.62
2022-06-16 $0.83 $1.21 $1.60
2022-06-17 $0.81 $1.20 $1.59
2022-06-21 $0.80 $1.19 $1.57
2022-06-22 $0.78 $1.17 $1.56
2022-06-23 $0.77 $1.16 $1.55
2022-06-24 $0.76 $1.14 $1.53
2022-06-27 $0.74 $1.13 $1.52
2022-06-28 $0.73 $1.12 $1.50
2022-06-29 $0.71 $1.10 $1.49
2022-06-30 $0.70 $1.09 $1.48
2022-07-01 $0.69 $1.07 $1.46
2022-07-05 $0.67 $1.06 $1.45
2022-07-06 $0.66 $1.04 $1.43

About Adaptimmune Therapeutics plc

Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on the provision of cancer immunotherapy products based on its T-cell receptor platform. Its platform enables to identify cancer targets; find and genetically engineer T-cell receptors (TCR); and produce TCR therapeutic candidates for administration to patients. The company’s lead program includes NY-ESO cancer antigen, which is in Phase 1/2 clinical trials for the... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!
.

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT